Research Funding

Since its earliest beginnings (1982), the Reeve Foundation has invested $87.7 million in research labs around the world to develop effective treatments for acute and chronic spinal cord injury. Decisions about our research investments are made with input from independent panels of scientific and clinical advisers and the our Board of Directors supports only research that is scientifically meritorious and highly relevant to repair of the damaged spinal cord.

Specifically this is how we have invested our research funds (a total of $41.2M) from 2004 to May 2010:

• $1.9M Neuroprotection
• $14M Regeneration (axon growth, remyelination, inhibition)
• $3.7M Cell transplantation (including stem cells)
• $4.9M Rehabilitation
• $3.6M Secondary complications (bowel, bladder, pain, spasticity, autonomic dysreflexia, etc.)
• $12.7M Therapy delivery and infrastructure (Clinical Trials Network and NeuroRecovery Network**)

**Participants in the NeuroRecovery Network have completed their in-patient rehabilitation, i.e., they are no longer considered acutely injured; many are several years or more post-injury.

All of us at the Reeve Foundation take pride in our programs and accomplishments. Our Quality of Life initiatives (care) have significantly improved the lives of so many who are living with SCI. The grand total for the Quality of Life grants program: over 1,700 grants totaling over 13 million dollars! And according to the Foundation's most recently published audit, 85.6% of monies raised were spent on programmatic services.

Spinal cord research today is exciting and promising because of our programs: discovery and translational research and delivering effective, safe treatments to the clinic are all major major players in our research portfolio.